Gladstone Investment Q3 EPS Miss by 169%, Net Assets Jump 129.5%

GAINGAIN

Gladstone Investment recorded Q3 EPS of -$0.16, missing estimates by 169%, on revenue of $25.1M, slightly below projections. Despite a net investment loss of $6.5M due to 50.3% expense growth, the company reported $2.2M net realized gains and $70.2M unrealized appreciation, boosting net assets by 129.5%.

1. Q3 Earnings Per Share Falls Short Significantly

Gladstone Investment reported an EPS of –$0.16 for its third fiscal quarter ending December 31, 2025, missing consensus estimates of $0.23 by 169%. This result contrasts with the prior-year quarter’s EPS of $0.23 and represents the company’s largest negative surprise in over two years. Management attributed the shortfall to elevated interest expenses and mark-to-market adjustments on select debt investments.

2. Revenues Show Modest Year-Over-Year Growth Despite Estimate Miss

Total investment income for the quarter stood at $25.1 million, slightly below the consensus forecast of $25.8 million but up from $21.37 million a year ago. The 17.5% year-over-year increase in topline reflects strong performance in the secured loan portfolio and incremental income from newly originated credit facilities. However, revenues dipped 0.9% sequentially as a result of lower fee income and tighter spreads in certain specialty finance segments.

3. Operating Expenses Surge, Leading to Net Investment Loss

Operating expenses rose 50.3% to $31.6 million from $21.0 million in the prior quarter, driven by higher financing costs and increased administrative overhead. As a result, the company recorded a net investment loss of $6.5 million, a swing from net investment income of $4.3 million in the preceding quarter. The expense increase was primarily related to an uptick in interest rates on floating-rate debt and ramped-up staffing to support portfolio growth.

4. Significant Unrealized Appreciation Bolsters Net Assets

Gladstone Investment realized net gains of $2.2 million during the period and reported net unrealized appreciation of $70.2 million, up 29.2% from $54.4 million at the end of September. These valuation increases were largely driven by markups on seasoned middle-market loans and equity co-investments in healthcare services platforms. Overall, the net increase in net assets resulting from operations surged 129.5% to $65.9 million, reinforcing the balance sheet and providing dry powder for future deployments.

Sources

SZF